Back to results
US 12,447,242 B2Granted
Hemostatic devices and methods of use
AssigneeMedtronic, Inc.
InventorsSatish Pulapura, Fatima Buevich, Jorie S. Soskin, Franklin R. Mansfield, Kai R. Worrell, Charlie Wood, Jorge Alberto Trevino Blanco, Narvel M. Brooks, III
Life of this patent
Estimating the term…
Abstract
An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate and a hemostatic agent. The substrate includes a first piece and a second piece that is joined with the first piece. The first piece includes the hemostatic agent and the second piece includes an active pharmaceutical ingredient. Kits, systems and methods are disclosed.
Claims20
A surgical system comprising:
- an anchorage device configured to secure an implantable medical device within a patient's anatomy, the anchorage device comprising a substrate comprising a first piece and a second piece that is joined with the first piece to form a pocket configured for disposal of the implantable medical device, the first piece comprising collagen having a first hemostatic agent homogenously distributed therein, the anchorage device comprising a polymer having a second hemostatic agent dispersed therein, the polymer having the second hemostatic agent dispersed therein directly applied to at least one of the first piece and the second piece.
A surgical system comprising:
- an implantable medical device selected from the group consisting of cardiac monitors, defibrillators, pacemakers and left ventricle assist devices;
- and
- an anchorage device configured to secure the implantable medical device within a patient's anatomy, the anchorage device comprising a substrate comprising a first piece and a second piece that is joined with the first piece to form a pocket configured for disposal of the implantable medical device, the first piece comprising hydrolyzed collagen having a hemostatic agent homogenously distributed therein, the first piece comprising a first polymer that covers at least a portion of the first piece, the second piece comprising a second polymer that covers at least a portion of the second piece,
- wherein the first polymer is poly (D,L-lactide-co-glycolide) and has tranexamic acid dispersed therein, the first polymer having tranexamic acid dispersed therein directly applied to the first piece, and
- wherein the second polymer is a tyrosine-derived polyarylate and has a combination of rifampin and minocycline dispersed therein.
2 more elements
A surgical system consisting of:
- an implantable medical device selected from the group consisting of cardiac monitors, defibrillators, pacemakers and left ventricle assist devices;
- and
- an anchorage device configured to secure the implantable medical device within a patient's anatomy, the anchorage device comprising a substrate comprising a first piece and a second piece that is joined with the first piece to form a pocket configured for disposal of the implantable medical device, the first piece comprising collagen having a hemostatic agent homogenously distributed therein, the first piece comprising a first polymer that covers at least a portion of the first piece, the second piece comprising a second polymer that covers at least a portion of the second piece,
- wherein the first polymer is a tyrosine-derived polyarylate and has a combination of rifampin and minocycline dispersed therein, and
- wherein the second polymer is poly (D,L-lactide-co-glycolide) and has tranexamic acid dispersed therein, the second polymer having tranexamic acid dispersed therein directly applied to the second piece.
2 more elements
Dependencies are inferred from the claim text.